Exbumin® – Recombinant human albumin excipient
Optimized for excipient applications
Filters
Sort results
Reset
Apply
Name | Price | Qty | |
|---|---|---|---|
$1,140.00
|
|||
$8,170.00
|
Product Description
Exbumin® is a recombinant human serum albumin that is manufactured using good manufacturing practices at an ISO9001:2015 certified facility in Kansas, USA. It is blood-free and has been used in hundreds of thousands of injections. It is one of the few excipients available to improve viral stability for vaccines and gene therapies. Exbumin is also used to maintain tissue viability during cryopreservation or storage. Exbumin helps to stabilize cells and tissue used in cell therapy and regenerative medicine applications. Exbumin has been approved for use as an excipient in injectable therapeutics by regulatory agencies.
Advantages
- Regulatory support available
- Manufactured in the United States, in a tertiary-level, animal component-free, ISO 9001:2015 certified facility
- Raw materials, manufacturing equipment, and packaging are certified blood-free and animal-free.
- The host manufacturing system is from a non-animal and non-human source.
- The complete supply and manufacturing chain is owned and operated by InVitria.
- Includes sodium specification to control sodium content for final formulation
Why Select Exbumin® Over Yeast- and Plasma-Derived Albumin?
| EXBUMIN® (Plant-derived) | Yeast-derived ALBUMIN | Plasma-derived ALBUMIN |
|
|---|---|---|---|
| Approved excipient by FDA | ✅ | ❌ | ✅ |
| Approved excipient by EMA | ✅ | ❌ | ✅ |
| Approved excipient by PMDA | ✅ | ❌ | ✅ |
| Free of Animal Origin Adventitious Pathogens | ✅ | ✅ | ❌ |
| Recombinant | ✅ | ✅ | ❌ |
| Sustainable | ✅ | ❌ | ❌ |
| Scalable | ✅ | ❌ | ❌ |
| Human Exposure as an Excipient | ✅ | ❌ | ✅ |
| No Added Preservatives | ✅ | ❌ | ❌ |
| No Added Stabilizers | ✅ | ❌ | ❌ |
See the Terms page for more information about the trademarks and patents covering this product.
Reviews
There are no reviews yet.